Back to search

Article

Universal protection of allogeneic cell therapies from natural killer cells via CD300a agonism

2024-05-07

Abstract excerpt

Immunogenicity limits the persistence of off-the-shelf, allogeneic cell therapies and transplants. While ablation of human leukocyte antigen (HLA) removes most T cell and humoral alloreactivity, no solution has enabled universal protection against the resulting natural killer (NK) cell response. Here, we engineered Trans Antigen Signaling Receptors (TASR) as a new class of NK inhibitory ligands and discovered CD30...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
fbc6c641-3729-5c48-a293-1853394596f9
DOI
10.1101/2024.05.05.592600
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Universal protection of allogeneic cell therapies from natural killer cells via CD300a agonismDOI 10.1101/2024.05.05.592600
Select a neighboring publication to make it the new centre.